Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients

Abstract

Interleukin (IL)-18, an important mediator of innate and adaptive immunity, plays multiple roles in chronic inflammation, in autoimmune diseases, in a variety of cancers and in number of infectious diseases. IL-18 promoter polymorphisms have been also noted associated with various inflammatory diseases. We investigated the association of IL-18 promoter polymorphisms (−656T/G, −607A/C and −137C/G) with systemic lupus erythematosus (SLE) in Taiwan Chinese patients and controls. Six haplotypes (hts) were identified from the three promoter polymorphisms. The genotype distribution of the ht1 (GCC), ht2 (TAC), ht4 (GAC) and ht5 (TCC) were different in patients and controls (P<0.002). Moreover, the haplotype and genotype frequencies of ht1 were significantly increased in patients with discoid rash (P=0.045, odds ratio (OR): 2.01, 95% confidence interval (CI): 1.01–4.00; P=0.027, OR: 5.13, 95% CI: 1.41–18.68). In addition, the homozygous genotype ht1/ht1 was significant increased in patients with serositis (P=0.015, OR: 9.78, 95% CI: 1.55–61.73). These observations suggest that the three promoter polymorphisms contribute to the genetic background of SLE pathogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kotzin BL . Systemic lupus erythematosus. Cell 1996; 85: 303–306.

    Article  CAS  PubMed  Google Scholar 

  2. Nath SK, Kilpatrick J, Harley JB . Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794–800.

    Article  CAS  PubMed  Google Scholar 

  3. Wu MC, Huang CM, Tsai JJ, Chen HY, Tsai FJ . Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003; 12: 21–25.

    Article  CAS  PubMed  Google Scholar 

  4. Robak E, Sysa-Jedrzejowska A, Robak T, Smolewski P . Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 2006; 25: 225–233.

    Article  PubMed  Google Scholar 

  5. Chen JY, Wang CM, Ma CC, Chow YH, Luo SF . The −844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun 2005; 6: 123–128.

    Article  CAS  PubMed  Google Scholar 

  6. al-Janadi M, Raziuddin S . B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 1993; 20: 1885–1891.

    CAS  PubMed  Google Scholar 

  7. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S . Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58–67.

    Article  CAS  PubMed  Google Scholar 

  8. Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000; 18: 565–570.

    CAS  PubMed  Google Scholar 

  9. Sun KH, Yu CL, Tang SJ, Sun GH . Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 2000; 99: 352–360.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. de Faucal P, Godard A, Peyrat MA, Moreau JF, Soulillou JP . Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus. Ann Immunol (Paris) 1984; 135D: 161–172.

    CAS  Google Scholar 

  11. Wong CK, Ho CY, Li EK, Lam CW . Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589–593.

    Article  CAS  PubMed  Google Scholar 

  12. Wong CK, Li EK, Ho CY, Lam CW . Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 1078–1081.

    Article  CAS  Google Scholar 

  13. Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol 2002; 20: 535–538.

    CAS  PubMed  Google Scholar 

  14. Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H . Proinflammatory interferon-gamma-inducing monokines (interleukin-12, interleukin-18, interleukin-15) – serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw 2002; 13: 364–368.

    CAS  PubMed  Google Scholar 

  15. Aringer M, Smolen JS . Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344–347.

    Article  CAS  PubMed  Google Scholar 

  16. Calvani N, Richards HB, Tucci M, Pannarale G, Silvestris F . Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol 2004; 138: 171–178.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gillespie MT, Horwood NJ . Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev 1998; 9: 109–116.

    Article  CAS  PubMed  Google Scholar 

  18. Gracie JA, Robertson SE, McInnes IB . Interleukin-18. J Leukoc Biol 2003; 73: 213–224.

    Article  CAS  PubMed  Google Scholar 

  19. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393–1401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H . Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997; 159: 6156–6163.

    CAS  PubMed  Google Scholar 

  21. Marshall JD, Aste-Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G . Regulation of human IL-18 mRNA expression. Clin Immunol 1999; 90: 15–21.

    Article  CAS  PubMed  Google Scholar 

  22. Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002; 3: 394–399.

    Article  CAS  PubMed  Google Scholar 

  23. Giedraitis V, He B, Huang WX, Hillert J . Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–152.

    Article  CAS  PubMed  Google Scholar 

  24. Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006; 342: 1413–1416.

    Article  CAS  PubMed  Google Scholar 

  25. Nieters A, Linseisen J, Becker N . Association of polymorphisms in Th1, Th2 cytokine genes with hayfever and atopy in a subsample of EPIC-Heidelberg. Clin Exp Allergy 2004; 34: 346–353.

    Article  CAS  PubMed  Google Scholar 

  26. Shin HD, Kim LH, Park BL, Choi YH, Park HS, Hong SJ et al. Association of interleukin 18 (IL18) polymorphisms with specific IgE levels to mite allergens among asthmatic patients. Allergy 2005; 60: 900–906.

    Article  CAS  PubMed  Google Scholar 

  27. Kruse S, Kuehr J, Moseler M, Kopp MV, Kurz T, Deichmann KA et al. Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 117–122.

    Article  CAS  PubMed  Google Scholar 

  28. Pawlik A, Kurzawski M, Czerny B, Gawronska-Szklarz B, Drozdzik M, Herczynska M . Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 2006; 67: 415–418.

    Article  CAS  PubMed  Google Scholar 

  29. Germer S, Higuchi R . Single-tube genotyping without oligonucleotide probes. Genome Res 1999; 9: 72–78.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Hamann L, Hamprecht A, Gomma A, Schumann RR . Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol Methods 2004; 285: 281–291.

    Article  CAS  PubMed  Google Scholar 

  31. Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1999; 1: 45–52.

    Article  CAS  PubMed  Google Scholar 

  32. Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL . Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 2004; 5: 484–492.

    Article  CAS  PubMed  Google Scholar 

  33. Mok CC, Lanchbury JS, Chan DW, Lau CS . Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090–1095.

    Article  CAS  PubMed  Google Scholar 

  34. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA . A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997; 40: 2207–2211.

    Article  CAS  PubMed  Google Scholar 

  35. Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J . Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001; 2: 363–366.

    Article  CAS  PubMed  Google Scholar 

  36. Tanaka Y, Nakashima H, Hisano C, Kohsaka T, Nemoto Y, Niiro H et al. Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 1999; 49: 266–271.

    Article  CAS  PubMed  Google Scholar 

  37. Nakashima H, Inoue H, Akahoshi M, Tanaka Y, Yamaoka K, Ogami E et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187–190.

    Article  CAS  PubMed  Google Scholar 

  38. Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Komai-Koma M et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167: 5338–5347.

    Article  CAS  PubMed  Google Scholar 

  39. Smolen JS, Steiner G, Aringer M . Anti-cytokine therapy in systemic lupus erythematosus. Lupus 2005; 14: 189–191.

    Article  CAS  PubMed  Google Scholar 

  40. Haus-Seuffert P, Meisterernst M . Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem 2000; 212: 5–9.

    Article  CAS  PubMed  Google Scholar 

  41. Dailey L, Roberts SB, Heintz N . Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev 1988; 2: 1700–1712.

    Article  CAS  PubMed  Google Scholar 

  42. Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51: 3347–3349.

    Article  CAS  PubMed  Google Scholar 

  43. Sivalingam SP, Yoon KH, Koh DR, Fong KY . Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 2003; 62: 498–504.

    Article  CAS  PubMed  Google Scholar 

  44. Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005; 6: 211–216.

    Article  CAS  PubMed  Google Scholar 

  45. Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

    Article  CAS  PubMed  Google Scholar 

  46. Stephens M, Donnelly P . A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by China Medical University (CMU95-142), China Medical University Hospital (DMR-91-003) and National Science Council in Taiwan (NSC95-2314-B-039-035).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F-J Tsai.

Additional information

Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, YJ., Wan, L., Lee, CC. et al. Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun 8, 302–307 (2007). https://doi.org/10.1038/sj.gene.6364387

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364387

Keywords

This article is cited by

Search

Quick links